who initiates the patient to begin the compassionate care program? the company in a formal request to the FDA or the physician sends a list of names to the company?
thx!
Are you speaking of a drug that already has a compassionate use clause? If so, your doctor contacts the pharma co. or a local participating cf center regarding enrolling you. It is a leg of the clinical trial and thus you will have to travel to a participating hospital if your own hospital is not participating.
I was involved in the Expanded Access program for Aztreonam Lysine (Cayston) for several years before it got FDA approval.
Participation was through my CF center. The center was a participant in the Expanded Access program. Not all centers were. They applied for me and supplied the drug. There was no cost - until it got FDA approval.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.